Skip to content
EntityQ48969152· pop 14· linked from 27 articles

Also known as RG7916, RO7034067

Risdiplam, sold under the brand name Evrysdi, is a medication used to treat spinal muscular atrophy (SMA) and is the first oral medication approved to treat this disease by the US Food and Drug Administration (FDA).

Key facts

Drug.image
Risdiplam.svg
Drug.image_class
skin-invert-image
Drug.tradename
Evrysdi
Drug.DailyMedID
Risdiplam
Drug.pregnancy_AU
D
Drug.routes_of_administration
By mouth
Drug.ATC_prefix
M09
Drug.ATC_suffix
AX10
Drug.legal_AU
S4
Drug.legal_CA
Rx-only
Drug.legal_US
Rx-only
Drug.legal_EU
Rx-only
Drug.CAS_number
1825352-65-5
Drug.PubChem
118513932
Drug.DrugBank
DB15305
Drug.ChemSpiderID
67886354
Drug.UNII
76RS4S2ET1
Drug.KEGG
D11406

via Wikipedia infobox

Wikidata facts

Mass
401.1964083560002
Show 3 more facts
canonical SMILES
CC1=CC(=NN2C1=NC(=C2)C)C3=CC(=O)N4C=C(C=CC4=N3)N5CCNC6(C5)CC6
chemical formula
C₂₂H₂₃N₇O
Commons category
Risdiplam
Sources (2)

via Wikidata · CC0

~5 min read

Article

12 sections
Contents
  • Medical uses
  • Adverse effects
  • Pharmacology
  • Mechanism of action
  • Efficacy
  • Society and culture
  • Legal status
  • Names
  • Compassionate use
  • References
  • Further reading
  • External links

Risdiplam, sold under the brand name Evrysdi, is a medication used to treat spinal muscular atrophy (SMA) and is the first oral medication approved to treat this disease by the US Food and Drug Administration (FDA).

Risdiplam is a survival of motor neuron 2-directed RNA splicing modifier.

Connections

Categories